Cascade Metrix (CM) is a medical technology company working within a new paradigm in critical care. The company will introduce an automated critical care blood analyzer that will revolutionize the bedside testing of hospitalized patients whose care and recovery is dependent on repetitive, around-the-clock measurements of critical blood parameters. This innovative and proprietary ex-vivo blood analysis system is first being applied to the automated measurement of glucose, and lactate in critically ill patients to achieve tight glycemic control. Additional parameters for early sepsis detection and management like hemoglobin and central venous oxygen saturation are also expected to be added over time.
CM is also actively exploring investment/partnership opportunities with firms in the medical technology and related areas. Please contact us for further details.